(Q38468151)

3 September 2017

title

The need for a national infrastructure to improve the rational use of therapeutics (English)

1 reference

3 September 2017

1 reference

1

Robert M Califf

1 reference

3 September 2017

publication date

1 June 2002

1 reference

Pharmacoepidemiology and Drug Safety

3 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 September 2017

volume

11

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

319-327

1 reference

The safety of newly approved medicines: do recent market removals mean there is a problem?

3 September 2017

cites work

1 reference

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease

21 January 2018

1 reference

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

21 January 2018

1 reference

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

21 January 2018

1 reference

Assessment and reporting of clinical pharmacology information in drug labeling

21 January 2018

1 reference

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost

21 January 2018

1 reference

The price of progress: prescription drugs in the health care market

21 January 2018

1 reference

The pause that refreshes, or does it? Mechanisms in torsades de pointes

21 January 2018

1 reference

Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives

21 January 2018

1 reference

Pharmacogenetics and drug-induced arrhythmias

21 January 2018

1 reference

Improving clinical decisions and outcomes with information: a review

21 January 2018

1 reference

Guided medication dosing for inpatients with renal insufficiency

21 January 2018

1 reference

Registry for torsades de pointes with drug treatment exists

21 January 2018

1 reference

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

21 January 2018

1 reference

Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial

21 January 2018

1 reference

Will Genetics Revolutionize Medicine?

21 January 2018

1 reference

Contraindicated use of cisapride: impact of food and drug administration regulatory action

21 January 2018

1 reference

Lack of an apparent association between intussusception and wild or vaccine rotavirus infection

21 January 2018

1 reference

Good news for experimental concept but bad news for clinically effective therapy

21 January 2018

1 reference

Aspirin use is low among United States outpatients with coronary artery disease

21 January 2018

1 reference

Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction

21 January 2018

1 reference

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

21 January 2018

1 reference

Drug labeling revisions-guaranteed to fail?

21 January 2018

1 reference

Insurance and new technology: from hospital to drugstore

21 January 2018

1 reference

How do observational studies expand the evidence base for therapy?

21 January 2018

1 reference

Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey

21 January 2018

1 reference

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

21 January 2018

1 reference

Risk management of marketed drugs: FDA and the interface with the practice of medicine

21 January 2018

1 reference

Nutritional rickets in African American breast-fed infants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PDS.699

1 reference

3 September 2017

1 reference